Literature DB >> 17534375

How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network.

Mark Kroese1, Ron L Zimmern, Peter Farndon, Fiona Stewart, Joanne Whittaker.   

Abstract

The UK Department of Health supported the establishment of the UK Genetic Testing Network (UKGTN) in 2002. The UKGTN is a collaborative network of NHS molecular genetic laboratories that offer tests for human single gene germ-line disorders. Its objective is to provide high quality and equitable services for patients and their families who require genetic advice, diagnosis and management. The UKGTN has developed a 'Gene Dossier' process to evaluate genetic tests and recommend which tests will be provided by the National Health Service. This paper describes the UKGTN organisation and the 'Gene Dossier' process. A brief review of the UKGTN genetic test evaluation experience is presented.

Entities:  

Mesh:

Year:  2007        PMID: 17534375     DOI: 10.1038/sj.ejhg.5201867

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

Authors:  Caroline Fiona Wright; Mark Kroese
Journal:  Hum Genet       Date:  2009-11-20       Impact factor: 4.132

Review 2.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

3.  Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorder.

Authors:  Valentin Skryabin; Ilya Rozochkin; Mikhail Zastrozhin; Volker Lauschke; Johan Franck; Evgeny Bryun; Dmitry Sychev
Journal:  Pharmacogenomics J       Date:  2022-10-22       Impact factor: 3.245

4.  A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England.

Authors:  Catherine L Bennett; Sarah E Burke; Hilary Burton; Peter A Farndon
Journal:  BMC Health Serv Res       Date:  2010-05-14       Impact factor: 2.655

5.  The impact of human gene patents on genetic testing in the United Kingdom.

Authors:  Naomi Hawkins
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

6.  Application of personalized medicine to chronic disease: a feasibility assessment.

Authors:  Ruslan Dorfman; Zayna Khayat; Tammy Sieminowski; Brian Golden; Renee Lyons
Journal:  Clin Transl Med       Date:  2013-12-18

7.  Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Authors:  Ebun Omoyinmi; Ariane Standing; Annette Keylock; Fiona Price-Kuehne; Sonia Melo Gomes; Dorota Rowczenio; Sira Nanthapisal; Thomas Cullup; Rodney Nyanhete; Emma Ashton; Claire Murphy; Megan Clarke; Helena Ahlfors; Lucy Jenkins; Kimberly Gilmour; Despina Eleftheriou; Helen J Lachmann; Philip N Hawkins; Nigel Klein; Paul A Brogan
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  How is genetic testing evaluated? A systematic review of the literature.

Authors:  Erica Pitini; Corrado De Vito; Carolina Marzuillo; Elvira D'Andrea; Annalisa Rosso; Antonio Federici; Emilio Di Maria; Paolo Villari
Journal:  Eur J Hum Genet       Date:  2018-02-08       Impact factor: 4.246

9.  A proposal of a new evaluation framework towards implementation of genetic tests.

Authors:  Erica Pitini; Elvira D'Andrea; Corrado De Vito; Annalisa Rosso; Brigid Unim; Carolina Marzuillo; Antonio Federici; Emilio Di Maria; Paolo Villari
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

Review 10.  Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities.

Authors:  Sarah Briggs; Ingrid Slade
Journal:  Curr Genet Med Rep       Date:  2019-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.